Literature DB >> 12663043

Effects of D3.49A, R3.50A, and A6.34E mutations on ligand binding and activation of the cannabinoid-2 (CB2) receptor.

Wenke Feng1, Z H Song.   

Abstract

In several G protein-coupled receptors (GPCRs), the Asp-Arg-Tyr (DRY) motif at the bottom of third transmembrane domain and the amino acid at position 6.34 in the sixth transmembrane domain have been shown to play important roles in signal transduction. In this study, we propose that in the cannabinoid-2 (CB2) receptor, R3.50 in the DRY motif may be crucial for interacting with G proteins, and D3.49 and A6.34 may be important for constraining the receptor in an inactive conformation. To test our hypothesis, R3.50A, D3.49A, and A6.34E mutations of the human CB2 receptor were made by site-directed mutagenesis. These mutant receptors were stably transfected into human embryonic 293 cells, and their ligand binding and signal transduction properties were analyzed. Similar to other GPCRs, R3.50 of the CB2 receptor is crucial for signal transduction. Unlike other GPCRs, D3.49 and A6.34 of the CB2 receptor do not seem to be important for keeping the receptor in an inactive state. Furthermore, D3.49A and A6.34E mutations abolished ligand binding, and all three mutations abolished constitutive activity of the wild-type CB2 receptor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12663043     DOI: 10.1016/s0006-2952(03)00005-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  15 in total

1.  Mutations of CB1 T210 produce active and inactive receptor forms: correlations with ligand affinity, receptor stability, and cellular localization.

Authors:  Aaron M D'Antona; Kwang H Ahn; Debra A Kendall
Journal:  Biochemistry       Date:  2006-05-02       Impact factor: 3.162

2.  hCB2 ligand-interaction landscape: cysteine residues critical to biarylpyrazole antagonist binding motif and receptor modulation.

Authors:  Richard W Mercier; Ying Pei; Lakshmipathi Pandarinathan; David R Janero; Jing Zhang; Alexandros Makriyannis
Journal:  Chem Biol       Date:  2010-10-29

Review 3.  Targeting the cannabinoid CB2 receptor: modelling and structural determinants of CB2 selective ligands.

Authors:  A Poso; J W Huffman
Journal:  Br J Pharmacol       Date:  2007-11-05       Impact factor: 8.739

4.  Structural basis of G protein-coupled receptor-Gi protein interaction: formation of the cannabinoid CB2 receptor-Gi protein complex.

Authors:  Jagjeet S Mnpotra; Zhuanhong Qiao; Jian Cai; Diane L Lynch; Alan Grossfield; Nicholas Leioatts; Dow P Hurst; Michael C Pitman; Zhao-Hui Song; Patricia H Reggio
Journal:  J Biol Chem       Date:  2014-05-22       Impact factor: 5.157

5.  Molecular basis for dramatic changes in cannabinoid CB1 G protein-coupled receptor activation upon single and double point mutations.

Authors:  Caitlin E Scott; Ravinder Abrol; Kwang H Ahn; Debra A Kendall; William A Goddard
Journal:  Protein Sci       Date:  2013-01       Impact factor: 6.725

Review 6.  Understanding functional residues of the cannabinoid CB1.

Authors:  Joong-Youn Shim
Journal:  Curr Top Med Chem       Date:  2010       Impact factor: 3.295

7.  The importance of hydrogen bonding and aromatic stacking to the affinity and efficacy of cannabinoid receptor CB2 antagonist, 5-(4-chloro-3-methylphenyl)-1-[(4-methylphenyl)methyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]hept-2-yl]-1H-pyrazole-3-carboxamide (SR144528).

Authors:  Evangelia Kotsikorou; Frank Navas; Michael J Roche; Anne F Gilliam; Brian F Thomas; Herbert H Seltzman; Pritesh Kumar; Zhao-Hui Song; Dow P Hurst; Diane L Lynch; Patricia H Reggio
Journal:  J Med Chem       Date:  2013-08-14       Impact factor: 7.446

8.  Species differences in cannabinoid receptor 2 and receptor responses to cocaine self-administration in mice and rats.

Authors:  Hai-Ying Zhang; Guo-Hua Bi; Xia Li; Jie Li; Hong Qu; Shi-Jian Zhang; Chuan-Yun Li; Emmanuel S Onaivi; Eliot L Gardner; Zheng-Xiong Xi; Qing-Rong Liu
Journal:  Neuropsychopharmacology       Date:  2014-11-06       Impact factor: 7.853

9.  Identification of raloxifene as a novel CB2 inverse agonist.

Authors:  Pritesh Kumar; Zhao-Hui Song
Journal:  Biochem Biophys Res Commun       Date:  2013-04-20       Impact factor: 3.575

Review 10.  Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer.

Authors:  M T M van Jaarsveld; J M Houthuijzen; E E Voest
Journal:  Oncogene       Date:  2015-12-07       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.